Insider Selling: Insulet Corp. COO Unloads 86,000 Shares of Stock (PODD)
Insulet Corp. (NASDAQ:PODD) COO Charles Liamos unloaded 86,000 shares of the stock on the open market in a transaction that occurred on Friday, January 3rd. The stock was sold at an average price of $36.02, for a total transaction of $3,097,720.00. Following the completion of the transaction, the chief operating officer now directly owns 77,316 shares in the company, valued at approximately $2,784,922. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
A number of research firms have recently commented on PODD. Analysts at Raymond James upgraded shares of Insulet Corp. from a “market perform” rating to an “outperform” rating in a research note to investors on Friday, November 22nd. They now have a $43.00 price target on the stock. Separately, analysts at Jefferies Group raised their price target on shares of Insulet Corp. from $38.00 to $46.00 in a research note to investors on Friday, November 8th. They now have a “buy” rating on the stock. Finally, analysts at Canaccord Genuity raised their price target on shares of Insulet Corp. from $40.00 to $45.00 in a research note to investors on Friday, November 8th. They now have a “buy” rating on the stock. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company’s stock. Insulet Corp. presently has a consensus rating of “Hold” and an average target price of $35.33.
Insulet Corp. (NASDAQ:PODD) traded up 2.90% on Friday, hitting $36.87. 906,314 shares of the company’s stock traded hands. Insulet Corp. has a 52-week low of $20.87 and a 52-week high of $40.50. The stock’s 50-day moving average is $36.46 and its 200-day moving average is $34.93. The company’s market cap is $2.011 billion.
Insulet Corp. (NASDAQ:PODD) last issued its quarterly earnings data on Thursday, November 7th. The company reported ($0.39) EPS for the quarter, missing the Thomson Reuters consensus estimate of ($0.16) by $0.23. The company had revenue of $61.10 million for the quarter, compared to the consensus estimate of $62.01 million. During the same quarter in the prior year, the company posted ($0.26) earnings per share. The company’s quarterly revenue was up 11.5% on a year-over-year basis. On average, analysts predict that Insulet Corp. will post $-0.88 earnings per share for the current fiscal year.
Insulet Corporation is primarily engaged in the development, manufacturing and sale of its OmniPod Insulin Management System (NASDAQ:PODD).
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.